[Progynova in the hormonal treatment of women with secondary amenorrhea after simple weight loss].
The estrogen-progestin treatment (Progynova + medroxyprogesterone acetate) were analyzed in group of 35 women after simple body weight loss. Women were between 16 and 20 years. We estimated hormonal profile (FSH, LH, E2) in those women. This estimation took place before treatment, after 3 months of treatment (Progynova 2 mg) and after subsequent 3 months (Progynova 1 mg). We observed significant increase of LH and estradiol concentrations after 3 months of therapy. Increase of LH and estradiol after 6 months was not significant. Increase of FSH after 3 and 6 months of therapy was not significant.
Warenik-Szymankiewicz
A
A
Kliniki Endokrynologii Ginekologicznej IGiP AM w Poznaniu.
Meczekalski
B
B
Wiza
M
M
Halerz-Nowakowska
B
B
Korcz-Maciejewska
M
M
D000293:Adolescent; D000328:Adult; D000568:Amenorrhea / Q000188:drug therapy*; D004958:Estradiol / Q000031:analogs & derivatives* / Q000097:blood / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D005640:Follicle Stimulating Hormone / Q000097:blood / Q000378:metabolism; D006801:Humans; D007986:Luteinizing Hormone / Q000097:blood / Q000378:metabolism; D008525:Medroxyprogesterone / Q000494:pharmacology / Q000627:therapeutic use*; D045167:Progesterone Congeners / Q000494:pharmacology / Q000627:therapeutic use*
D045167:Progesterone Congeners; D004958:Estradiol; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D008525:Medroxyprogesterone
Ocena skuteczności klinicznej preparatu Progynova w leczeniu wtórnego braku miesiaczki po odchudzaniu.